IL17A and rheumatoid arthritis: Several data indicate that the inflammatory cytokine mediator IL-23 is included in Th17 cell activation and differentiation with subsequent IL-17A production that actively participates in tissue inflammation and destruction, confirming its pivotal role in RA’s pathogenesis (Schinocca et al., 2021; Tsukazaki and Kaito, 2020).